Privium Fund Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-36,593
Closed -$3.85M 61
2025
Q4
$3.85M Sell
36,593
-27,800
-43% -$2.61M 0.71% 24
2025
Q3
$5.4M Buy
64,393
+5,300
+9% +$437K 0.97% 20
2025
Q2
$4.83M Buy
59,093
+18,000
+44% +$1.43M 1.04% 15
2025
Q1
$3.69M Sell
41,093
-31,518
-43% -$2.94M 0.96% 20
2024
Q4
$7.22M Buy
72,611
+12,500
+21% +$1.29M 1.63% 14
2024
Q3
$6.83M Buy
60,111
+16,314
+37% +$1.94M 1.7% 17
2024
Q2
$5.59M Sell
43,797
-1,700
-4% -$219K 1.43% 21
2024
Q1
$6M Sell
45,497
-42,481
-48% -$5.24M 1.6% 19
2023
Q4
$9.96M Hold
87,978
2.78% 10
2023
Q3
$9.06M Sell
87,978
-11,300
-11% -$1.22M 2.69% 10
2023
Q2
$11.3M Buy
99,278
+7,450
+8% +$846K 3.24% 8
2023
Q1
$9.77M Sell
91,828
-328
-0.4% -$35.4K 3.28% 9
2022
Q4
$10.2M Hold
92,156
3.87% 8
2022
Q3
$7.98M Buy
92,156
+4,000
+5% +$357K 2.9% 10
2022
Q2
$8.04M Sell
88,156
-10,000
-10% -$887K 2.66% 11
2022
Q1
$8.05M Sell
98,156
-15,000
-13% -$1.18M 1.78% 16
2021
Q4
$8.73M Buy
+113,156
New +$9.01M 1.73% 18

Other funds holding MRK

Privium Fund Management's MRK Position: Q1 2026 in Review

Privium Fund Management sold out of Merck (MRK) in Q1 2026, closing a stake of 36,593 shares — an estimated $3.85M sold.

Privium Fund Management first reported a position in MRK in Q4 2021 and held it in 17 quarters. The position peaked at $11.3M in Q2 2023. 3,796 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Privium Fund Management reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Privium Fund Management sold 36,593 Merck shares in Q1 2026, an estimated $3.85M.
  • Privium Fund Management first reported a position in Merck in Q4 2021 and held it in 17 quarters.
  • Privium Fund Management's Merck position peaked at $11.3M in Q2 2023.
  • 3,796 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Privium Fund Management's 13F filing for Q1 2026, filed 5 May 2026.